BIOMAT Database Logo BIOMAT Database Logo

Subcutaneous heparin injection. 1978

J F Mitchell, and K A Mark

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J F Mitchell, and K A Mark
Site for subcutaneous heparin injection.
January 1993, Archives of internal medicine,
J F Mitchell, and K A Mark
Site for subcutaneous heparin injection.
January 1992, Archives of internal medicine,
J F Mitchell, and K A Mark
Skin necrosis following subcutaneous heparin injection.
November 1995, The Australasian journal of dermatology,
J F Mitchell, and K A Mark
"Low-dose heparin"--significance of subcutaneous injection.
August 1976, Thrombosis research,
J F Mitchell, and K A Mark
Postoperative thrombosis prophylaxis with subcutaneous heparin-Ca injection.
January 1990, Therapia Hungarica (English edition),
J F Mitchell, and K A Mark
Four heparin preparations: anti-Xa potentiating effect of heparin after subcutaneous injection.
June 1976, Thrombosis and haemostasis,
J F Mitchell, and K A Mark
Skin necrosis after subcutaneous low molecular weight heparin injection.
July 1995, American journal of hematology,
J F Mitchell, and K A Mark
Intermittent subcutaneous injection of calcium heparin for anticoagulant control.
July 1971, The Medical journal of Australia,
J F Mitchell, and K A Mark
Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection.
August 2009, Immunology and allergy clinics of North America,
J F Mitchell, and K A Mark
Novel subcutaneous low-molecular-weight heparin injection technique to reduce post-injection bruising.
July 2019, Phlebology,
Copied contents to your clipboard!